| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Looker Benjamin is a General Counsel at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 6,517 | $3.67 | $23,897.84 | -1.7% | -25.8% | - | |
| Oct 17, 2025 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 1,248 | $2.62 | $3,275.38 | -0.3% | +13.8% | - | |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 6,267 | $2.80 | $17,572.67 | -1.6% | +36.4% | - | |
| Jul 17, 2025 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 1,304 | $1.13 | $1,469.61 | -0.3% | +103.2% | - | |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 6,422 | $1.15 | $7,398.14 | -1.6% | +155.0% | - | |
| Apr 19, 2023 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 1,290 | $1.27 | $1,640.88 | -1.5% | +19.8% | +42.7% | |
| Jan 18, 2023 | ESPR Esperion Therapeutics, Inc. | General Counsel | Sell | 6,347 | $7.00 | $44,403.61 | -9.0% | -80.6% | -68.4% |